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ABSTRACT
Primary monolayer cultures of normal and malignant human mammary epithelial
cells were tested for fibronectin by indirect immunofluorescence using antisera
specific for fibronectin . This protein was not detectable on either the normal or
malignant epithelial cells . Similar results were obtained for normal and malignant
mouse mammary epithelial cell cultures . Control normal and transformed fibro-
blasts exhibited the expected result : the normal cells were positive and the
transformed cells were negative . With the use of supernatant fluids from the same
cultures or an agar-overlay assay on viable cells, high levels of plasminogen-
dependent fibrinolytic activity were detectable in both the normal and malignant
mammary cells . Thus, two characteristics that distinguish normal from trans-
formed fibroblasts do not serve as markers of malignancy inmammary epithelial/
carcinoma systems .
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Over the past few years, two putative markers of
neoplastic transformation have been extensively
studied in a number of laboratories . The first, a
large external transformation-sensitive glycopro-
tein (LETS . protein), is lost, or greatly reduced in
amount, when normal fibroblasts are transformed
in vitro with oncogenic viruses or chemical carcin-
ogens (reviewed in references 14, 42, and 47) . This
protein, now identified as the major surface gly-
coprotein of all tested normal fibroblasts and en-
dothelial cells (4, 17, 18, 48, 49), is identical, or
very similar, both physicochemically and immu-
nologically, to several glycoproteins previously ob-
served in, or isolated from, sera and cell cultures
120
(i.e ., CIg, SFA, CSP, fibronectin ; for nomenclature
and relationship of these proteins, see review by
Yamada and Olden, reference 47) . Various bio-
chemical and cellular functions have been pro-
posed for fibronectin (the name to be used in this
report), although none of these has yet been clearly
demonstrated (47) . However, fibronectin has gen-
erally been accepted as a (negative) transforma-
tion-related marker for fibroblast/sarcoma sys-
tems in vitro .
Plasminogen activator is a second marker that
is reported to distinguish normal from transformed
fibroblast cells . Only low levels of plasminogen-
dependent fibrinolytic activities are exhibited by
normal cells, whereas high levels are generally
associated with transformed cells (30, 31, 41) . A
number of glycoproteins, including fibronectin,
have been suggested to be in vivo substrates for
J . CELL BIOLOGY© The Rockefeller University Press - 0021-9525/80/01/0120/11 $1 .00
Volume 84
￿
January 1980
￿
120-130plasmin, the product of the plasminogen activator
(5, 15, 40). Surface expression of fibronectin and
the level of plasminogen activator, however, may
not be directly related (25) .
Because most human cancers are carcinomas, it
is important to establish the relevance of these two
cellular characteristics to neoplastic transforma-
tion in epithelial systems. To date, there have been
few reports in which these characteristics have
been examined in epithelial cells (8, 20, 45) . We
have developed methods that allow normal and
malignant human mammary epithelial cells to be
routinely grown as monolayers in primary culture :
normal cells are isolated from the breast fluids of
healthy women, and malignant cells are isolated
from primary breast carcinomas (19) . We have
demonstrated that these cell cultures and a per-
manent line ofhuman breast cancer cells, MCF-7
(38), are applicable to a number of experimental
studies ofthe cell biology ofhuman breast cancers
(10, 19, 35, 43, 50, 51) . Using this system and
mouse mammary epithelial cells, we investigated
the expression of fibronectin and plasminogen
activator to determine whether they would serve
as markers for transformation of mammary epi-
thelial cells . In addition, several epithelial cell lines
not of breast origin were examined to establish
whether there is a correlation between these two
characteristics and the neoplastic transformation
of epithelial cells in general .
MATERIALS AND METHODS
Cell Cultures
Breast milk samples were obtained from normal women who
were weaning or hadjust weaned their infants (l0). The human
mammary epithelial (HME) cells were pelleted, washed, and
seeded onto coverslips in 35-mm tissue culture dishes in milk cell
(MC) medium (19), which consists of Dulbecco's modified Ea-
gle's medium (MEM) (pH 6.8), 15% fetal calf serum (FCS), 10
,ug/ml insulin, 5 wg/ml ovine prolactin, and 15 mM N-2-hydrox-
yethyl piperazine-N'-2-ethane sulfonic acid (HEPES) buffer (pH
6.8) . Under these conditions, the cells grew intoconfluent epithe-
lial islands, whichwe have previously shown to possess all of the
ultrastructural features of normal mammary epithelium (35) .
Cells were released from primary human breast carcinomas
by enzymatic digestion without agitation for 18 h at 37°C in
culture medium supplemented with 5% FCSand containing 0.5
mg/ml collagenase(l9). Epithelial cell aggregates and fibroblasts
were recovered by centrifugation, washed, and seeded into cul-
ture dishes as described for the normalHME cells.
Primary cultures of normal and malignant mouse mammary
epithelial cells were established from BALB/c lactating mam-
mary glands and from GR mammary tumors, respectively, as
described by Voyles and McGrath (44) and McGrath and Blair
(28) .
MCF-7 cells derived from a pleural effusion of a female
patient with a scirrhous carcinoma of the breast (38) exhibit
human, breast, epithelial, and malignant cell characteristics (2,
29, 36) . D-549, a normal fibroblast cell line derived from human
foreskin, and D-562, a human carcinoma cell line derived from
the pleural effusion of an adenocarcinoma of the throat (32),
were obtained from Dr. W. Peterson, Children's Hospital of
Michigan . HBL-100, a line ofputative normalHME cells isolated
from colostrum (33), was obtained from Dr . E. Gaffney, Penn-
sylvania State University, University Park, Pa. Normal human
fetal kidney cells were provided by Dr.W . Peterson, Children's
Hospital ofMichigan. The latter cells grow in continuous culture,
exhibit epithelial-like morphology, but have not been designated
as a permanent cell line . Fibroblastic cell cultures derived from
normal human liver, testis, and lung were also provided by Dr .
W . Peterson . All of the above cell lines or continuous cultures
and the primary cultures ofGR and BALB/c mouse mammary
epithelial cells, were grown in Dulbecco's MEM supplemented
with 15% FCS . 3 d before fixation for the inrmunofuorescence
(IF) assay, cultures were replenished with MC medium and
grown under the same conditions as the HME cells in primary
culture (19) . Insome co-cultivation experiments, D-549 fibroblast
cells were treated for 18 h with 2,ug/ml mitomycinC in medium,
washed, trypsinized, andadded to the HME cell cultures .
IF Microscopy
Rabbit antisera againsthumanplasma cold-insoluble globulin
and against LETS protein purified from hamster cells were
generously provided by Drs . L.-B . Chen (8) and R. O. Hynes
(27), respectively . Goat antiserum against chick embryo fibro-
blast fibronectin was the gift of Dr. K . M. Yamada (46) . Cells on
glass coverslips were washed twice with serum-free Dulbecco's
MEMand five times with phosphate-buffered saline(PBS), fixed
for 30 min at 4°C in 10% phosphate-buffered formalin, and then
washed five times with PBS and five times with distilled water .
To facilitate detection of intracellular antigens, some cells were
fixed for 10 min at -20°C with acetone. Fixed cells were air-
dried and stained by the indirect IF technique . The primary
antifibronectin sera prepared by Chen, Harvard University,
Cambridge, Mass ., Hynes, Massachusetts Institute of Technol-
ogy, Cambridge, Mass ., and Yamada, National Institutes of
Health, Bethesda, Md ., were used at dilutions of 1 :80, 1:25, and
20 hg/ml, respectively . The secondary antisera, fluorescein iso-
thiocyanate- (FITC) conjugatedgoat anti-rabbit IgG (Antibodies
Inc., Davis, Calif.) or FITC-conjugated rabbit anti-goat IgG
(Miles Laboratories, Inc., Elkhart, Ind.), were used at dilutions
of 1:30 and 1:10, respectively . Cells were incubated in the primary
antiserum for 30 min at 37°C in a humidified chamber, washed
with PBS, and incubated for an additional 30 min with the
secondary serum . Stained cells were washed five times with PBS
and twice with distilled water, air-dried, and mounted with
glycerol:PBS (1 :1) . As a control for each tested antiserum, cells
were incubated in normal rabbitserum or preimmune goatserum
at the same dilutions as the antisera .
IF-stained cells were examined with a Leitz photomicroscope
equipped with epi-illumination andadark-field condensor. Pho-
tographs were taken with Kodak Tri-X film.
Plasminogen-dependent Fibrinolytic Activity
Qualitative measurementofplasminogen activatorproduction
by individual epithelial colonies wasmade using the casein-agar-
overlay assay described by Goldberg (1l). Cells were washed in
two changes of serum-free MC medium and then overlaid with
serum-free Dulbecco's MEM containing 0.5% agar, 2% nonfat
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plasminogen . Before use, the dog serum was acid treated as
described by Ossowski et al. (30) to destroy the naturally occur-
ring serum inhibitors of plasmin. The overlay mixture was al-
lowed to solidify at room temperature, and the cultures were
incubated for 18-20 h at 37°C in a humidified CO z incubator.
Plasminogen activator production was detected as cleared zones
of caseinolysis superimposed over individual epithelial colonies .
The plasminogen dependence of the caseinolytic activity was
established by omitting plasminogen from the overlay mixture;
under these conditions no lysis was observed .
Extracellular plasminogen activator activity elaborated by the
cells in culture was determined by adding aliquots ofconditioned
media to [3H]fibrin-coated Petri dishes and measuring the release
of [''HJfibrinopeptides essentially as described by Barret et al (3) .
Acid-treated dogserum was used as a source of plasminogen in
all assays . The number ofHME cells that grow out in replicate
primary cultures is variable . We have found that the most
accurate method for determining the expression of plasminogen
activator in response to steroid hormones is to initially measure
the activity in the absence of hormone and subsequently to
measure theactivitygenerated by the sameculture in the presence
of test hormones . Exponentially growing cells in 35-mm culture
dishes were washed five times with serum-free MC medium and
then incubated for 24 h in 1.0 ml of serum-free MC medium
containing 0.001% ethanol . This medium was clarified by cen-
trifugation, and the supernatant fluid was stored at -20°C . An
additional 1 .0 ml of serum-free MC medium containing the
desired hormone(s)dissolved in 0.001% ethanol was added to the
same culture dishes, and the cultures were incubated for an
additional 24h. Conditioned media were cleared and stored until
testing . Under these serum-free conditions, no change in cell
number per culture was observed during the 48-h experimental
period, asdetermined bydirect microscopiccounts of cell number
per colony, and, if no hormones were added during the second
incubation, the amount of plasminogen activator released was
the same as during the first incubation (Table 1) .
RESULTS
Surface-exposedFibronectin
The presence or absence of fibronectin was
tested in IF assays using specific antifibronectin
antisera (see Materialsand Methods).Theefficacy
ofthesemethodswas first establishedon fibroblast
(or endothelial) control cells . Under our experi-
mental conditions, 3T3 cells expressed ahigh level
of fibronectin (Fig . 1 a), whereas SV40-trans-
formed 3T3 cells expressed a much reduced level
(Fig . 16). These data agree well with previous
reports on surface expression of Fibronectin by
these cells (12, 16). Fig. 1 c shows that normal
human foreskin fibroblasts D-549 exhibit readily
detectable surface Fibronectin in culture . We also
observed (data not shown) that fibroblastic cells
cultured from normal human liver, testis, amniotic
fluid, and lung also express high levels of fibro-
nectin .
No IF reactivity was detected when these cells
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TABLE I
Presence ofPlasminogen Activator in Human Mam-
mary Cell Cultures and Cell Cultures Not of Breast
Origin
Plasminogen-dependent
fibrinolylic activity/
Cells tested
￿
100 Al medium-
equivalent
urokinase
'H cpm
￿
units x 10'
*The 0 . l -ml aliquots of 24-h conditioned media of the
cultures were assayed for fibrinolytic activity as de-
scribed in Materials and Methods. Urokinase equiva-
lents were obtained by extrapolation andnormalization
from standard curves of urokinase activity included
with each assay .
Twoconsecutive 24-h incubations were performed for
culture C to test the continuity of release ofPlasmino-
gen activators within a48-h culture period .
§ Fresh medium was incubated at 37°C for 24 h in a
Petri dish without any cells .
were stained with normal rabbit serum or preim-
mune serum. Three different preparations of an-
tifibronectin serum, shown to be highly specific
for fibronectin (see Materials and Methods and
references 8, 27, and 46), were tested for their
reactivity on these cells, andthe same results were
obtained.
Normal HME cellswere examined to determine
whether they also express this surface protein. A
Primary or early passage cells
Normal humanmammary ep-
ithelial cells (5-10 x
10° cells/culture)
Culture A 30,615 7.3
Culture B 58,069 8.7
Culture Cf
1st 24 h incubation 71,464 9.3
2nd 24h incubation 68,775 9.2
Malignant human mammary
epithelial cells (5-10
x 10° cells/culture)
Culture A 82,424 10.1
Culture B 26,759 6.9
Cell lines
MCF-7, human breast carci- 37,142 7 .7
noma (1 x 10° cells)
D-562, human throat carci- 51,456 8.4
noma (1 x 104 cells)
HBL-100, human colostrum 17,495 5 .9
(1 x 10" cells)
D-549, human foreskin fibro- <200 <0 .I
blast (1 x 10 6 cells)
Control Medium§ 0 0
Background 1,240FIGURE I
￿
Indirect IF detection of fibronectin : (a) normal 3T3 cells ; (b) SV-40 transformed 3T3 cells;
(c)normal human foreskin fibroblast cells, D-549 .
FIGURE 2
￿
Indirect IF detection of fibronectin on normal HME cells in primary culture : (a) 22 d in
culture ; (b) 80 d in culture ; (c) normal HME cells co-cultivated with normal human foreskin fibroblasts,
D-549, for 30 d. a', b', and c' show the cell morphology of the same fields as in a, b, and c, respectively,
viewed using a dark-field condensor. Because the D-549 fibroblasts are much flatter than the normal
HMEcells, the abundant peripheral cytoplasm of the D-549 cells is not in the plane of focus in (c') .
FIGURE 3
￿
Indirect IF detection of fibronectin on malignant human mammary epithelial cells in primary
culture : (a) 17 d in culture ; (b) 26 d in culture ; (c) cell morphology of b viewed using a dark-field
condensor. The more flattened, less light-refracting cells in c, which exhibited fluorescence reactivity in b,
are stromal fibroblast cells.
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were tested . No IF reactivity was detectable on
these normal HMEcells (Fig . 2 a) . Cells fixedwith
either formalin or acetone were tested and the
results were identical, showing that both extracel-
lular and intracellular fibronectins were absent
from the normal HMEcells . Fibronectin could not
be demonstrated even at concentrations of antise-
rum 3- to 10-fold higher than the concentration
sufficient to show maximal staining of the control
cells (data not shown) .
Cultures of normal HME cells consist of indi-
vidual islands of contiguous cells (19) . It has been
reported (7) that surface expression of fibronectin
on some fibroblasts is dependent upon cell-to-cell
contact and time in culture. Therefore, to deter-
mine whether fibronectin expression by contig-
uous normal HME cells is a function of the time
the cells have been in culture, large islands of
confluentnormalHMEcells (>5,000 cells/colony)
were maintained in primary cultures for 30, 45,
and 80 d before IF testing . Again, no reactivity
was detectable on these cells (Fig . 26), suggesting
that expression of fibronectin is not induced on
the contiguous epithelial cells by prolonged cellu-
lar contact.
To establish that the lack of fibronectin staining
of normal HME cells is specific and not the result
of an artifact of the culture conditions used, we
co-cultivated positive control cells with normal
HME cells . D-549 cells, which express fibronectin
reactivity (Fig. 1 c), were treated with mitomycin
C (to prevent overgrowth of the culture with the
fibroblasts) and grown together with the normal
HME cells . Fig . 2c shows that after 30 d of co-
cultivation, the fibroblast feeder cells surrounding
the epithelial islandsshowed readily detectable IF
reactivity. No reactivity was observed within the
HME islands .
To determine whether malignant HME cells
also lack fibronectin, we tested cells in primary
culture derived from four breast carcinomas (19) .
Fig . 3 shows that, whereas the stromal fibroblasts
present in these cultures exhibit a high level of
fibronectin, themalignant epithelial cells arecom-
pletely unreactive . Similar data, obtained using
paraffin sections of human breast carcinomas,
were recently reported by Linder et al . (21), al-
though these investigators did not test for expres-
sion of fibronectin on the counterpart normal
HME cells.
In addition to examining primary cultures of
human breast carcinoma cells, we also examined
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the expression of surface fibronectin on cells of a
well-characterized malignant human mammary
epithelial cell line MCF-7 (38) . Fig . 4 shows that
MCF-7 cells that have maintained many of the
characteristics of breast carcinoma cells through
several years of serial passage (36, 43, 50, 51) also
do not express detectable levels of fibronectin .
Our data demonstrate that both normal and
malignantHME cells lack surface-exposed fibro-
nectin . To determine whether this is unique to
human mammary cells, we tested mouse mam-
mary epithelial cells isolated either from normal
lactating glands or from spontaneous mammary
tumors . Figs . 5 and 6 show that, like the human
cells, mouse mammary epithelial cells exhibit no
surface-exposed fibronectin in primary culture .
Other investigators have reported that some ep-
ithelial-like cells have detectable levels of surface
fibronectin (8, 9, 37), but it has not been estab-
lished whether this expression is tissue or organ
specific, or whether it is related to the develop-
mental origin of the cells tested. A number of
other epithelial cell lines were, therefore, tested for
their expression of this cell-surface protein under
our experimental conditions . Fig . 7 shows that
normal human fetal kidney cells, D-562, a cell line
derived from a human throat adenocarcinoma
(32), and HBL-100 cells derived from human co-
lostrum (33) all express readily detectable levels of
surface fibronectin.The distribution of fibronectin
was pel .' ';ellular on the human kidney cells and
cellular on the D-562 and HBL-100 cells. D-562
and HBL-100 cells were found to deposit fibro-
nectin only between the cell surface and substra-
tum or between cells, and not on the upper cell
surface . Although the exact embryonic origin of
some of these cells hasnotbeen clearly established
(43), all the cells assume a polygonal morphology
and exhibit an epithelial-like growth pattern in
culture .
Plasminogen Activators
Fibrinolytic activity was determined by two
methods. As shown in Fig . 8, we found that both
normal and malignant human mammary epithe-
lial cells express readily detectable fibrinolytic ac-
tivities as determined by the casein-agar-overlay
technique (11) . These activities were totally de-
pendent on the presence of plasminogen . Clearing
of the casein overlay was observed only over the
islands of epithelial cells; macrophages or histio-
cytes in the MC cultures and stromal fibroblasts
in the breast tumor cultures (19) were totally in-FIGURE 4
￿
(a) Indirect IF detection of fibronectin on human breast carcinoma cells, MCF-7; (b) cell
morphology ofthe same field viewed using a dark-field condensor .
FIGURE 5
￿
(a) Indirect IF detection of fibronectin on normal BALB/c mouse mammary epithelial cells
in primary culture ; (b) cell morphology of the same field viewed using a dark-field condensor .
FIGURE 6
￿
(a) Indirect IF detection of fibronectin on malignant GR mouse mammary epithelial cells in
primary culture ; (b) cell morphology of the same field viewed using a dark-field condensor .
FIGURE 7
￿
Indirect IF detection of fibronectin on (a) normal human kidney epithelial cells in continuous
culture; (b) human throat carcinoma cells, D-562, and (c) human HBL-100 cells .
active in this assay . The malignantHME cell line
MCF-7 expressed a similar level of plasminogen
activator in culture, as did the primary cultures of
normal and malignantHMEcells .
Using an insoluble 3H-labeled fibrin layer as the
substrate and serum-free medium conditioned by
the cells as theenzyme source (3,and see Materials
and Methods), we quantitated the plasminogen-
dependent fibrinolytic activities released by cells
in culture . A total of sixnormal HME cell cultures
and four malignantHME cell cultures were tested.
Table I shows that high levels of plasminogen
activator are consistently observed in culture fluids
conditioned by both normal and malignantHME
cells . Because the number of epithelial cells may
vary from one primary culture to another, and
because cell clumping and the presence of non-
epithelial cell types in these cultures makes con-
ventional cell counting by trypsinization inap-
plicable (19), it has notbeen possible to determine
the exact specific activity of plasminogen activator
(i.e., enzyme units per cell) in either the normal or
malignant HME cells. However, on the basis of
microscopic estimation of epithelial cell number
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activities of the plasminogen activator in the nor-
mal and malignant cell cultures are similar, al-
though smaller quantitative differences cannot be
excluded at this time .
In addition to HME cells, a number of epithe-
lioid cell lines not of breast origin and one fibro-
blast cell line were also examined for production
of plasminogen activator . Allof the epithelial-like
cell cultures tested, including D-562 cells, HBL
100 cells, and normal human fetal kidney cells,
were found to exhibit high levels of plasminogen-
dependent fibrinolytic activity (Table 1) . However,
essentially no reactivity was observed for the nor-
mal human fibroblast cells, D-549 . These data
demonstrate that, in contrast to many fibroblast/
sarcoma systems (30, 31, 41), expression of plas-
minogen activator in vitro does not distinguish
126
FIGURE 8
￿
Agar-overlay assay of plasminogen-dependent fibrinolytic activities present in normal (a and
a') and malignant (b and b') HME cells in primary cultures . a and b were assayed in the presence of
plasminogen ; a' and b' in the absence of plasminogen . The cleared zones demonstrate the presence of
activity directly over each ofthe epithelial colonies in the culture .
THE JOURNAL OF CELL BIOLOGY " VOLUME 84, 1980
normal from malignant epithelial cells .
Mammaryepithelial cells areknown to be target
cells for polypeptide hormones and sex steroids
(34) . Because several characteristics of the human
breast cancer cell line MCF-7 (13, 22-24, 51),
including plasminogen activator production (6),
have been found to be responsive to progesterone
and estradiol, the possible effects of these hor-
mones on the expression of plasminogen activator
of HME cells in primary culture were examined .
Table II shows that a combination ofprogesterone
and ,Q-17 estradiol (each at 1 x 10-8M) caused up
to a 10-fold increase in the plasminogen-depend-
ent fibrinolytic activity ofnormal HMEcells . Hor-
monal stimulation of these activities in primary
cultures ofmalignantHMEcells was also observed
but appeared to be less pronounced . NormalHME
cells treated with progesterone, estradiol, or dexa-TABLE II
Hormonal Stimulation ofPlasminogen-dependent Fibrinolytic Activities in Human Mammary Epithelial (HME)
Cell Cultures
methasone alone exhibited similar or slightly aug-
mented levels (<30%) of plasminogen activator
when compared with normal HME cultures that
received no hormones (data not shown) . The data
shown in Table II thus demonstrate that levels of
plasminogen activator released by HME cells in
culture are stimulated by progesterone and estra-
diol, and that this hormonal regulation is likely to
be a characteristic of HME cells, irrespective of
whether they are derived from normal or malig-
nant tissues .
Our observations of the expression of Fibronec-
tin and plasminogen activators in human cells are
summarized in Table III .
DISCUSSION
We have observed that neithernormal nor malig-
nant mammary epithelial cells in primary culture
express fibronectin . This is characteristic of both
human and mouse systems . Control experiments
confirm that the lack of IF reactivity observed for
these cells is not the result of insensitivity of the
IF assay nor does it result from the lack of suffi-
cient cellular contact in the cultures . Normal fi-
broblasts stain positively for Fibronectin ; co-culti-
vation of fibroblasts with the epithelial cells does
not alter the reactivity ofeither cell type . Thewell-
characterized permanent line ofhuman breast car-
cinoma cells MCF-7 also exhibits no reactivity in
' Number of cells in the cultures tested was 5 x 103 to 5 x 10° .
$ Relative levels of plasminogen activator were determined in 100 td aliquots of control (no hormone) and hormone-
treated conditioned mediafrom thesame cell cultures, as described in Materials and Methods and Table I .
TABLE III
Expression of Surface Fibronectin and Plasminogen
Activator in Human Cell Cultures
' Surface fibronectin and plasminogen activator were
assayed by indirect immunofluorescence staining and
agar-overlay assays, respectively.
the indirect IF assay for fbronectin .
Fibronectin is a component of basement mem-
brane (39) . The adjacent epithelium is considered
bymany to be responsible forbasement membrane
synthesis, and one might predict that normal epi-
thelial cells, including the mammary epithelial
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Cells
Primary cultures
Fibronectin'
Plasminogen
activator
Normal human mammary - +
epithelial cells
Malignanthumanmammary - +
epithelial cells
Cell lines
MCF-7, human breast car- - +
cinoma
HBL-100, human colostrum + +
D-549, human foreskin fi- + -
broblast
D-562, human throat ade- + +
nocarcinoma
Continuous culture
Human fetal kidney cell + +
Cell tested' Treatment Relative
equivalent urokinase units
activity$
x 10`/100 It/medium
Normal HME cells
Culture 1 None 3.01 ± 0.11 P<0.01 + progesterone and estradiol 5.25 ± 0.16
Culture 2 None 0.81 ± 0.05 P <0.01 + progesterone and estradiol 8.42 ± 0.47
Culture 3 None 1 .62 t 0.38 P <0.01 + progesterone and estradiol 9.57 t 0.33
Malignant HME cells
Culture 1 None 1.81 ± 0.21 P <0.05 + progesterone and estradiol 2.76 t 0.12
Culture 2 None 5.18 ± 0.22 P<0.05 + progesterone and estradiol 6.57 ± 0.31cells examined in this study, would be positive for
fibronectin expression . Our data suggest that this
may not be the case . The breast fluid cells tested
in this study were collected as exfoliated cells and
it is possible that these cells represent terminally
differentiated cells that may have lost the capacity
to synthesize basement membrane products such
as fibronectin. However, it is unlikely that these
cells are terminally differentiated, because the ma-
jority of these cells isolated from breast fluids
eventually grow into large epithelial colonies that
exhibit characteristics ofmammary epithelium in
vivo (35) . These cells can be successfully grown as
secondary and tertiary cultures under appropriate
conditions (19), and yet they consistently remain
negative for fibronectin expression . Furthermore,
the mouse mammary epithelial cells examined
were not exfoliated cells but were derived from the
mammary gland of a pregnant mouse, and they
were also negative for fibronectin expression .
Another possibility is that mammary epithelial
cells may in fact be synthesizing fibronectin but
secreting it into the culture fluid . This seems un-
likely because negative results were obtained when
acetone-fixed cells were tested, indicating that no
detectable intracellular pool ofsoluble fibronectin
is present . However, a more direct test of this
possibility, by immunoprecipitation of metabol-
ically radiolabeled culture fluids, for example, was
not done .
In addition to HME cells, a number of other
human epithelial cell lines were also tested for
fibronectin expression. We found that HBL-100
cells, normal human fetal kidney cells, and D-562
human throat adenocarcinoma cells expressed de-
tectable fibronectin . The HBL-100 cell line was
originally derived from human colostrum and is
proposed to be a normal HME cell line (33),
although the HBL-100 cells do not possess char-
acteristics normally associated with mammary ep-
ithelium (43) . It is possible, judging from their
morphology and expression of fibronectin, which,
as we have shown here, is absent from bona fide
normal or malignant mammary epithelial cells,
thatHBL-100 is derived from vascular endothelial
cells .
With the exception ofnewborn hamster kidney
cells and some rat liver cells (8), all primary cul-
tures of normal and malignant (or transformed)
epithelial cells previously tested, including those
of pig periodontal ligament (20), mouse salivary
gland and bladder (45), and mouse mammary
tissue (1), lack the distinctive fibrillar or patch
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distribution of surface fibronectin. In contrast,
some tumorigenic animal carcinoma cell linesmay
exhibit appreciable amounts of fibronectin, as
shown by Wigley and Summerhayes (45) and Asch
(1) .
Our data are in general agreement with those of
others (20, 45) and suggest that there is no direct
correlation between malignancy or neoplastic
transformation and loss of fibronectin in epithe-
lium/carcinoma systems, including mammary ep-
ithelium of both mouse and human origin .
Whether the presence of fibronectin on some of
the epithelial-like cells examined by us and others
(1, 8, 37, 45) is (a) tissue specific, (b) the reflection
of an endothelial origin of some of these cells, or
(c) the result of the cells' dedifferentiation or se-
lection through long-term passage of the cell lines
in culture, has yet to be determined . Should future
studies support the latter two alternatives, absence
of fibronectin might serve as a useful marker for
differentiated epithelial cells in culture . Marceau
et al. (26) have reported that the major surface
protein of rat liver epithelial cells is a glycoprotein
of 80,000 daltons, which is clearly distinct from
the 225,000-dalton fibronectin isolated from rat
liver fibroblast cells .
Using two independent assay methods, we
found that both normal and malignantHME cells
exhibit readily detectable levels of plasminogen
activator in primary cultures . The enzyme activi-
ties can be augmented in these cultures by a
combination ofprogesterone and estradiol at phys-
iological concentrations, irrespective of whether
the epithelial cells are derived from normal or
malignant breast tissues. These results strongly
suggest that the presence of plasminogen activator
is not a marker for HME cell transformation, nor
does the hormonal stimulation of this protease
activity appear to be functionally related to malig-
nant transformation of these cells .
The absence ofsurface fibronectin in HME cells
does not necessarily result from the release of
plasminogen activators from these cells in culture .
This is supported by the observation that co-cul-
tivation of either normal or malignant HME cells
with human fibroblast cells did not inhibit fibro-
nectin expression on the fibroblast cells . Further-
more, there is no apparent direct correlation be-
tween the presence of fibronectin and the presence
of plasminogen activator in the various cells tested
(Table III), and cells that express plasminogen
activator may, or may not, express fibronectin .
In conclusion, two cellular characteristics, theexpression of fibronectin and the expression of
plasminogen activator, whichmaydistinguish nor-
mal from transformed or malignant fibroblasts in
culture, do not serve as markers for malignancy of
mammary epithelial cells. This observation under-
scores the need to identify additional markers for
malignancy and the need to test these markers in
epithelium/carcinoma systems, which comprise
the vast majority ofhuman cancers.
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